Trequinsin
Alternative Names: HL 725Latest Information Update: 15 Sep 2004
At a glance
- Originator Aventis
- Class Antihypertensives; Antiplatelets
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension